Santhera Pharmaceuticals
SANN.SW
#8555
Rank
S$0.15 B
Marketcap
$13.09
Share price
-1.70%
Change (1 day)
-17.66%
Change (1 year)

EPS for Santhera Pharmaceuticals (SANN.SW)

EPS in 2018 (TTM): -$50.75

According to Santhera Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$16.75. In 2022 the company made an earnings per share (EPS) of -$16.75 an increase over its 2021 EPS that were of -$23.51.

EPS history for Santhera Pharmaceuticals from 2006 to 2018

Annual EPS

Year EPS Change
2022-$16.75-28.75%
2021-$23.51-69.23%
2020-$76.40222.64%
2019-$23.68-77.65%
2018-$105.95-5.34%
2017-$111.9252.2%
2016-$73.53-593.67%
2015$14.90-165.72%
2014-$22.67-2.15%
2013-$23.16-81.35%
2012-$124.2115.64%
2011-$107.41145.81%
2010-$43.70-53.37%
2009-$93.71-152.24%
2008$179.38-270.36%
2007-$105.29-33.09%
2006-$157.36